Press Releases

DateTitleLink
December 7, 2019Aleta Biotherapeutics Presents In Vivo Results of a Novel Therapeutic Designed to Reactivate CAR T Cells in Patients Who Relapse After CAR T TherapyVIEW PDF
December 2, 2019Aleta Biotherapeutics Announces Oral Presentation at the 61st American Society of Hematology Annual Meeting (ASH)VIEW PDF
September 5, 2019Aleta Biotherapeutics Announces Appointments to Board of DirectorsVIEW PDF

Media